Tobacco-Focused Patient Navigation to Address Barriers to Utilization of Community-Based Smoking Cessation Services in Primary Care

Completed

• Conditions: Minority Smokers
• Interventions: Behavioral: Patient Navigator

• Registration Number: NCT01678118
• Lead Sponsor: Memorial Sloan Kettering Cancer Center

Brief Summary

Patient navigators have been shown to assist people seeking cancer screening and other medical services. The purpose of this study is to see whether a patient navigator can link smokers to available community resources shown to help smokers quit smoking.

Detailed Description

Not available

Study Timeline

• Study Start: 2011-04
• Study First Submitted: 2012-08-30
• Study First Submitted QC: 2012-08-31
• Study First Posted: 2012-09-03
• Status Verified: 2021-07
• Primary Completion: 2021-07-20
• Study Completion: 2021-07-20
• Last Update Submitted: 2021-07-21
• Last Update Posted: 2021-07-27

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 16

Inclusion Criteria

• Age ≥ 18 years
• Self-reported current daily smoker, as verified with a portable alveolar carbon monoxide (CO) analyzer (24 hour point prevalence); CO levels ≥ 8 ppm.
• English and/or Spanish-speaking
• Referred to the navigation program by their primary care clinician
• At baseline, participants report at least thinking about quitting (i.e., Contemplation or Preparation stages of readiness to quit).

Read More

Exclusion Criteria

• Serious, untreated psychiatric illness (e.g., schizophrenia,) or active substance abuse likely to preclude adherence to the protocol

Read More

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
minority smokers	Patient Navigator	A single arm ABA design will be used to pilot a tobacco-focused patient navigation (TPN) intervention for low income, minority smokers.

Primary Outcome Measures

Name	Time	Method
patient navigation (TPN) feasibility	1 year	To evaluate the study's potential in terms of its reach, effectiveness, adoption, implementation, and maintenance (RE-AIM) of the intervention, tobacco-dependent patients will be asked to complete an intake interview and a telephone follow-up interview (at 3 to 6 months post-intervention).

Trial Locations

Locations (2)

Ralph Lauren Center for Cancer Care and Prevention; 🇺🇸 New York, New York, United States

Heritage Health Center; 🇺🇸 New York, New York, United States